Artemis Therapeutics
Holding Companies & Conglomerates · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
18 E 16th St Rm 307, New York, New York,...Phone Number
(646) 233-1454Website
www.artemis-therapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 3
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
2
2
4
2
3
About Artemis Therapeutics
Artemis Therapeutics Inc. does not have significant operations. Previously, it was involved in the development of agents for the prevention and treatment of severe and life-threatening infectious diseases. The company is based in New York, New York. Artemis Therapeutics Inc. is a subsidiary of Tonak Ltd.Explore more
Artemis Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Artemis Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Artemis Therapeutics has new funding data
Artemis Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Artemis Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Artemis Therapeutics launches new products
Check out if Artemis Therapeutics is spiking on competitors!
Earning: See what the market has to say on Artemis Therapeutics recently announced quarterly report
Click to see if Artemis Therapeutics had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Artemis Therapeutics
Recommended Actions
Find VP level buyers at Artemis Therapeutics
Find more new buyers
Compare Similar Companies to Artemis Therapeutics
Compare insights from companies similar to Artemis Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Artemis Therapeutics is experiencing very low activity levels compared to other companies in the Holding Companies & Conglomerates sector.
What does this means?
Artemis Therapeutics is drawing exceptional interest within the Holding Companies & Conglomerates industry, suggesting notable developments or strong market momentum, learn more about Artemis Therapeutics.
Artemis Therapeutics Tech Stack
A closer look at the technologies used by Artemis Therapeutics
Artemis Therapeutics News & Media
Data Presented At The 31st International Conference For Antiviral Research Demonstrate Artemis Therapeutics' Artemisone May Be An Effective Inhibitor Of Human CMV Replication
SAN DIEGO, June 12, 2018 /PRNewswire/ -- Artemis Therapeutics, Inc. (OTCQB: ATMS), ("Artemis" or the "Company"), a pharmaceutical company developing new therapies for the treatment of infectious diseases, including cytomegalovirus and malaria, today announced that new data on its lead...New Data Demonstrate Artemis Therapeutics' Artemisone May Be An Effective Inhibitor Of Human CMV Replication
SAN DIEGO, June 7, 2018 /PRNewswire/ -- Artemis Therapeutics, Inc. (OTCQB: ATMS), ("Artemis" or the "Company"), a pharmaceutical company developing new therapies for the treatment of infectious diseases, including cytomegalovirus and malaria, today announced that new data on its lead...Artemis Therapeutics Announces Additional Patent Issuance For Artemisone For The Treatment Of Viral Infections
SAN DIEGO, April 16, 2018 /PRNewswire/ -- Artemis Therapeutics, Inc. (OTCQB: ATMS), ("Artemis" or the "Company"), a pharmaceutical company developing new therapies for the treatment of life-threatening infectious diseases, today announced the decision by the Japanese Patent Office to allow...Artemis Therapeutics Announces Issuance Of European Patent For Artemisone For The Treatment Of Viral Infections
NEW YORK, Nov. 28, 2017 /PRNewswire/ -- Artemis Therapeutics, Inc. (OTCQB: ATMS), ("Artemis" or the "Company"), a pharmaceutical company developing new therapies to treat life-threatening infectious diseases, today announced the recent issuance by the European Patent Office (EPO) of Europe...
Read more news
Top Holding Companies & Conglomerates Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Artemis Therapeutics
Sign Up For FreeTo access detailed company insights
Artemis Therapeutics Inc. does not have significant operations. Previously, it was involved in the development of agents for the prevention and treatment of severe and life-threatening infectious diseases. The company is based in New York, New York. Artemis Therapeutics Inc. is a subsidiary of Tonak Ltd.... Read More
